• Nie Znaleziono Wyników

First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina

N/A
N/A
Protected

Academic year: 2022

Share "First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina"

Copied!
1
0
0

Pełen tekst

(1)

www.kardiologiapolska.pl

Kardiologia Polska 2017; 75, 1: 78; DOI: 10.5603/KP.2017.0003 ISSN 0022–9032

STUDIUM PRZYPADKU / CLINICAL VIGNETTE

Address for correspondence:

Jakub Podolec, MD, PhD, Department of Interventional Cardiology, Jagiellonian University College of Medicine and the John Paul II Hospital, ul. Prądnicka 80, 31–702 Kraków, Poland, e-mail: jjpodolec@gmail.com

Conflict of interest: none declared

Kardiologia Polska Copyright © Polskie Towarzystwo Kardiologiczne 2017

First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina

Pierwsza w Polsce implantacja 60-mm taperowanego stentu u pacjenta z niestabilną dławicą piersiową

Jakub Podolec, Łukasz Niewiara, Jakub Baran, Piotr Pieniążek, Krzysztof Żmudka

Interventional Cardiology Clinic, Jagiellonian University, Medical College, John Paul II Hospital, Krakow, Poland

Coronary artery disease is still a disease with high morbidity and mortality rates. Technology development is one of the most important factors among treatment methods and provides a personalised approach to patients. A 66-year-old patient was admit- ted to the Interventional Cardiology Clinic with symptoms of unstable angina, recently progressing up to class III according to Canadian Cardiovascular Society classification. The patient was

diagnosed and treated for arterial hypertension and dyslipi- daemia, without other significant comorbidities. Three weeks earlier the patient underwent coronary angiography, which revealed a single, long lesion in the left anterior descending (LAD). After Heart Team consultation a single coronary artery by-pass graft (CABG) to the LAD was proposed as the best treatment option. The patient did not agree to undergo CABG and was re-qualified to percutaneous coronary intervention.

Coronary angiography confirmed critical long stenosis in the proximal/mid LAD (Fig. 1A, B). An extra back-up therapeutic catheter was introduced via the right femoral artery. A Ryiujin 1.25/10 mm balloon was used to cross and pre-dilate the proximal lesion. Then the lesion was treated with long infla- tions of a non-compliant 2.5/15 mm balloon with pressures up to 22 atm. After intracoronary vascular ultrasound (IVUS) for artery size and plaque morphology estimation (Fig. 2A) a tapered sirolimus drug-eluting stent Meril, Biomime Morph, 60 mm long, with proximal 3.0 mm and distal 2.5 mm diam- eter was prepared for this patient. The stent was introduced and implanted with pressure of 10 atm without any compli- cations. Post dilatation was performed with a 3.25/15 mm non-compliant balloon with 8 atm pressure in the distal and up to 24 atm in the mid and proximal parts of the stent. The guide wire was easily repositioned to a diagonal branch and the “kissing balloon” technique was applied to finalise the result (Fig. 3). Proper apposition of the stent was confirmed with IVUS (Fig. 2B). The patient was discharged. Long and complex lesions are becoming more common in patients pre- senting to interventional cardiology cath-labs. New, tapered, long drug-eluting stents are designed to cover the whole lesion and adjust to native vessel anatomy. A single-stent technique is favourable, avoiding the risk of sub-optimal apposition of overlapping stents, and after correct lesion preparation with non-compliant balloon it is easy and safe to introduce. We present a unique case of a very long 60-mm tapered stent implantation in a patient with unstable angina. The long term-results of long stent implantations still need to be assessed in clinical trials; however, our first experiences are promising.

Figure 1. A, B. Left anterior descending lesion prior to percutaneous coronary intervention

A B

Figure 2. Intracoronary vascular ultrasound cross-sectional view of left anterior descending prior to (A) and after stent implantation (B)

A B

Figure 3. A, B. Left anterior descending after successful 60 mm, 3.0/2.5 mm tapered stent implantation

A B

Cytaty

Powiązane dokumenty

In contrast, the latest generation of drug-eluting stents (DES) and their antiprolif- erative properties have tremendously improved angiographic and clinical outcomes of patients

In the present study, it was sought to de- termine the 1-year clinical follow-up of patients treated with the thin strut BP-coated sirolimus- eluting stent (BP-SES) versus

Address for correspondence: Takao Konishi, MD, PhD, Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, West 7, North

The selection of ap- propriate stent size and stent optimization to avoid under-expansion and malapposition due to the stenotic lesion of ectatic RCA led to an assessment

Study flow chart; COACT — CathOlic University of Korea: percutAneous Coronary inTervention; DES — drug eluting stents; GFR — estimated glomerular filtration rate; MDRD

Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting

Ce ell p prra accyy:: Celem pracy jest ocena skutecznoœci inwazyjnego leczenia choroby wieñcowej za pomoc¹ implantacji stentów powlekanych rapamycyn¹ (DES) w wybranej grupie

Wysokociœnieniowa predylatacja balonowa, poprze- dzaj¹ca implantacjê DES w celu leczenia ISR powoduje uzyskanie bezpoœrednio po zabiegu wiêkszego œwiat³a na- czynia w miejscu